Alert detail
FDA Approval: SODIUM BICARBONATE (SODIUM BICARBONATE) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA220790Specialty: Multi-specialtyAdded: 7/15/2026Effective: July 9, 2026billing update
What changed
Amneal sodium bicarb IV: Part B injectable, verify J-code assignment.
Who’s affected: Multi-specialty billing teams · Effective: July 9, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.